AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)
Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Exosomes for NAION
What are ophthalmology clinical trials?
Ophthalmology clinical trials are research studies designed to evaluate new treatments, therapies, or diagnostic methods for eye diseases and conditions. These trials focus on a wide range of ophthalmic issues, including but not limited to glaucoma, age-related macular degeneration (AMD), diabetic retinopathy, cataracts, and retinal diseases. Clinical trials in ophthalmology may test new medications, surgical techniques, laser treatments, or medical devices to improve vision, prevent blindness, or manage symptoms of eye diseases.
The data collected from these trials helps advance understanding and development of better treatment options, ultimately aiming to enhance eye health and visual outcomes for patients.
Why are clinical trials for ophthalmology important?
With a vast range of eye conditions and diseases falling under the ophthalmology umbrella, clinical research in this area is highly important. Ophthalmology clinical trials are crucial for driving the development of new and more effective treatments for eye diseases and conditions, which can significantly impact vision and quality of life.
Clinical trials for ophthalmology help researchers to evaluate novel medications, surgical techniques, and diagnostic tools, potentially leading to breakthroughs in managing or curing a range of conditions. Ophthalmology clinical trials play a key role in reducing the burden of visual impairment and blindness, enhancing eye health, and promoting better visual outcomes for future patients.
What types of clinical trials are used for ophthalmology?
Clinical trials in ophthalmology employ various types and methodologies to evaluate new treatments, technologies, and diagnostic approaches for eye diseases. Researchers will determine the design and type of clinical trial they use depending on the study objectives.
Prevention trials
Prevention trials in ophthalmology are used to explore and evaluate strategies designed to prevent the onset or progression of eye diseases. These trials test various approaches, such as lifestyle changes, nutritional interventions, or early treatments, to reduce the risk of developing conditions like age-related macular degeneration, diabetic retinopathy, or glaucoma.
By identifying effective preventive measures and interventions, these trials aim to improve long-term eye health, delay disease onset, and reduce the burden of visual impairment. Participants in prevention trials contribute to understanding how to better safeguard eye health and develop strategies to maintain or enhance vision throughout life.
Observational trials
Researchers use ophthalmology observational trials to gather data on the natural progression of eye diseases, treatment responses, and the impact of various factors without administering experimental interventions. Patients are monitored over time to understand how conditions like glaucoma, age-related macular degeneration, or diabetic retinopathy develop and respond to standard care.
These trials help identify patterns, risk factors, and outcomes, providing insights into disease mechanisms and the effectiveness of existing treatments. The findings from observational trials contribute to improving diagnostic criteria, refining treatment strategies, and enhancing patient management in ophthalmology.
Treatment trials
Ophthalmology researchers can use treatment trials when testing the safety and effectiveness of new treatments, procedures, or devices for managing eye diseases and conditions. Participants in these trials receive experimental interventions, such as novel medications, advanced surgical techniques, or innovative laser therapies, and are closely monitored for their effects on vision and eye health.
Treatment trials for ophthalmology assess how the given interventions impact disease progression, symptom relief, and overall visual outcomes. By evaluating these new approaches, researchers using this trial type can support the identification of more effective treatments, improve patient care, and advance the field of ophthalmology.
Participation in an ophthalmology clinical trial
Taking part in a clinical trial for ophthalmology offers many different benefits for participants, especially those already diagnosed with various eye conditions. It’s important to remember that participation in an ophthalmology clinical trial can also come with risks and considerations too.
Participant benefits
Access to cutting-edge treatments and technologies is one of the main benefits of participating in a clinical trial for ophthalmology. These treatments may not be available through standard care so participants will have first access to them. Participants usually receive close monitoring and specialized care from experts, which can lead to early detection of issues and personalized management of their eye condition. This high level of care can be an improvement to the treatment or care they receive outside the trial.
Additionally, involvement in a trial contributes to advancing medical research, helping to develop new therapies and improve treatment options for future patients. For some, participating may also provide an opportunity to experience potential improvements in vision and overall eye health.
Risks and considerations
Like any research study, participating in a clinical trial for ophthalmology involves risks and considerations. One such risk is the potential for exposure to unknown side effects from experimental treatments or procedures, which may be different from standard care or currently available treatments. There is also no guarantee that the new intervention will be effective or improve your condition.
In terms of considerations before signing up, participants might also face frequent medical visits, tests, and additional procedures, which can become burdensome and require a change in their daily routine.
Who can participate in a clinical trial for ophthalmology?
Eligibility for participating in a clinical trial for ophthalmology typically includes individuals diagnosed with specific eye conditions or diseases under investigation, such as glaucoma, age-related macular degeneration, or diabetic retinopathy. When establishing criteria, researchers will often consider factors like the severity of the condition, overall health, age, and previous treatments.
Some clinical trials for ophthalmology will focus on particular subgroups, such as those with early-stage disease or those who have not responded to standard treatments. Healthy volunteers may also be included in some trials for comparison purposes.
Unsure about participating in clinical trials? Read through our comprehensive guide to learn about the process, benefits, and potential impact of your involvement. Get the facts you need to make an informed decision today!
What to expect when participating in an ophthalmology clinical trial
Participants in a clinical trial for ophthalmology can first expect to undergo a detailed screening process to determine eligibility. This often includes medical evaluations and informed consent discussions. If enrolled, the clinical trial can begin as per the trial design. This could be in the form of receiving the assigned intervention, which could be a new treatment, procedure, or medical device. Participants are closely monitored through regular visits, tests, and assessments to evaluate the safety and effectiveness of the treatment.
Throughout the course of the trial, participants might need to follow specific protocols or lifestyle adjustments related to the trial. Throughout the process, the research team will regularly interact, providing support and ensuring participant safety while collecting valuable data to advance eye care and treatment.
How to enroll in a ophthalmology clinical trial
Enrolling in a clinical trial studying ophthalmology through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify Your Trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select Your Preferred Location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore Study Details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the Health Profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the Application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.